Pagenax

Pagenax ATC Classification

brolucizumab

Manufacturer:

Novartis

Distributor:

DKSH

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

ATC Classification

S01LA06 - brolucizumab ; Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.

Sign up for Free to continue reading

Sign up with email

Already a member? Sign in